We are live on ! Find out more
SP

Symmetry Partners Portfolio holdings

AUM $1.96B
1-Year Est. Return 19.83%
This Fund
S&P 500
This Quarter Est. Return
-2.38%
1 Year Est. Return
+19.83%
3 Year Est. Return
+58.53%
5 Year Est. Return
+62.51%
10 Year Est. Return
AUM
$1.84B
AUM Growth
-$42.4M
Cap. Flow
+$8.77M
Cap. Flow %
0.48%
Top 10 Hldgs %
34.87%
Holding
597
New
20
Increased
66
Reduced
201
Closed
70
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
451
Baxter International
BAX
$14.2B
$260K 0.01%
6,885
PANW icon
452
Palo Alto Networks
PANW
$297B
$255K 0.01%
2,172
COO icon
453
Cooper Companies
COO
$14.5B
$254K 0.01%
3,200
WBD icon
454
Warner Bros
WBD
$67.1B
$254K 0.01%
23,377
-2,535
-10% -$31.6K
XPO icon
455
XPO
XPO
$23.7B
$254K 0.01%
3,402
IP icon
456
International Paper
IP
$22B
$253K 0.01%
7,127
-3,287
-32% -$112K
CPB icon
457
Campbell Soup
CPB
$6.87B
$252K 0.01%
6,143
-64,828
-91% -$2.84M
FITB
458
Fifth Third Bancorp
FITB
$51.8B
$248K 0.01%
9,807
CBOE icon
459
Cboe Global Markets
CBOE
$29.9B
$246K 0.01%
1,573
EFX icon
460
Equifax
EFX
$21.4B
$245K 0.01%
1,336
-389
-23% -$79.4K
FWONK icon
461
Liberty Media Series C
FWONK
$25.8B
$245K 0.01%
3,936
-135
-3% -$9.26K
MANH icon
462
Manhattan Associates
MANH
$11.4B
$245K 0.01%
1,240
+107
+9% +$20.9K
SBS icon
463
Sabesp
SBS
$18.7B
$245K 0.01%
104,249
-23,184
-18% -$52.7K
AMCR icon
464
Amcor
AMCR
$22.1B
$244K 0.01%
5,330
-440
-8% -$21.2K
SGEN
465
DELISTED
Seagen Inc. Common Stock
SGEN
$244K 0.01%
1,151
BMRN icon
466
BioMarin Pharmaceuticals
BMRN
$12.4B
$243K 0.01%
2,748
MNST icon
467
Monster Beverage
MNST
$88.5B
$242K 0.01%
4,570
STE icon
468
Steris
STE
$23.1B
$242K 0.01%
1,102
APTV icon
469
Aptiv
APTV
$10.3B
$240K 0.01%
2,438
EQH icon
470
Equitable Holdings
EQH
$14.1B
$239K 0.01%
8,419
-1,327
-14% -$37.5K
EW icon
471
Edwards Lifesciences
EW
$51.7B
$239K 0.01%
3,453
-582
-14% -$46.8K
SJM icon
472
J.M. Smucker
SJM
$12.8B
$238K 0.01%
1,933
-11,595
-86% -$1.65M
KMB icon
473
Kimberly-Clark
KMB
$36.5B
$237K 0.01%
1,962
-2,321
-54% -$300K
OZK icon
474
Bank OZK
OZK
$5.61B
$237K 0.01%
6,390
ALNY icon
475
Alnylam Pharmaceuticals
ALNY
$29.3B
$236K 0.01%
1,331

Similar funds

Symmetry Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Symmetry Partners held 597 positions worth $1.84B, down 2.2% from $1.89B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Symmetry Partners's Q3 2023 filing shows 20 new, 66 increased, 201 reduced and 70 closed positions. Its largest new stake was Vanguard Morningstar Mid-Cap Value ETF: 172,053 shares worth $22.5M. The largest sale was State Street Materials Select Sector SPDR ETF, an estimated $11.5M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 6.6% a quarter earlier, followed by Industrials and Healthcare.

  • Symmetry Partners's largest Q3 2023 buy was Vanguard Morningstar Mid-Cap Value ETF: 172,053 shares worth $22.5M.
  • Symmetry Partners added most to iShares MSCI USA Momentum Factor ETF in Q3 2023, an estimated $23.4M increase.
  • Symmetry Partners's biggest Q3 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $8.21M.
  • Symmetry Partners fully exited State Street Materials Select Sector SPDR ETF in Q3 2023, selling an estimated $11.5M.
  • Symmetry Partners's ten largest holdings make up 35% of its $1.84B portfolio in Q3 2023.
  • Symmetry Partners opened 20 new positions and closed 70 in Q3 2023.
  • Symmetry Partners's portfolio value fell 2.2% quarter-over-quarter to $1.84B.

Based on Symmetry Partners's 13F filing for Q3 2023, filed 10 Oct 2023.